IDEAYA Biosciences Receives Fast-Track Designation for IDE161 in Advanced Breast Cancer
IDEAYA Biosciences has announced that the U.S. Food and Drug Administration (FDA) has granted fast-track designation to its development program focused on IDE161. This program aims to investigate IDE161 as…